Discover 1,846 paid clinical trials in Tennessee. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Whether you're a healthy volunteer interested in paid studies or someone looking for trials focused on specific conditions, Tennessee offers a wide variety of clinical research options. Leading facilities in Nashville, Memphis, and Knoxville are currently seeking participants, providing opportunities for individuals to access innovative treatments and specialized healthcare.
Filter
1
Filter results
Results: 1,846
A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
for
Pulmonary Arterial Hypertension
Location: Boston MA, Valhalla NY, New York NY, Durham NC,
Sponsor: Inhibikase Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07365332
Phase3, Recruiting
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
for
Locally Advanced or Metastatic Solid Tumors, Colorectal Cancer,
Location: Fairfax VA, Denver CO, Sarasota FL, Nashville TN,
Sponsor: ArriVent BioPharma, Inc.
Sex: All
Age: 18+
Code: NCT07066657
Phase1, Recruiting
Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica
for
Polymyalgia Rheumatica
Location: Sherbrooke, Trois-Rivieres, Willow Grove PA,
Sponsor: Sanofi
Sex: All
Age: 50+
Code: NCT07286214
Recruiting
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
for
Ovarian Cancer, Endometrial Cancer,
Location: Boston MA, Fairfax VA, Orlando FL, Nashville TN,
Sponsor: ArriVent BioPharma, Inc.
Sex: Female
Age: 18+
Code: NCT07755436
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Identifying Effective and Cost-Conscious Maintenance Daratumumab Dosing
for
Multiple Myeloma
Location: Nashville TN
Sponsor: Eden Biltibo
Sex: All
Age: 18 - 70
Code: NCT07485647
Phase2, Recruiting
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
for
Small Cell Lung Cancer (SCLC ),
Location: New York NY, Hackensack NJ, Nashville TN, St Louis MO,
Sponsor: Moonlight Bio, Inc
Sex: All
Age: 18+
Code: NCT07488923
Phase1, Recruiting
DG1 Spectacle Lens for Myopia Progression Control in Children
for
Myopia
Location: Virginia Beach VA, Garner NC, Ocoee FL, Gainesville FL,
Sponsor: HOYA Lens Thailand LTD.
Sex: All
Age: 7 - 10
Code: NCT06781931
Recruiting
Care Transitions in Renal Disease Patients
for
Renal Disease
Location: Franklin TN
Sponsor: Fresenius Medical Care North America
Sex: All
Age: 18+
Code: NCT01842776
Recruiting
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
for
Biliary Tract Cancer, Breast Cancer, Cervical Cancer,
Location: Boston MA, Miami FL, Denver CO, Nashville TN,
Sponsor: ModeX Therapeutics, An OPKO Health Company
Sex: All
Age: 18+
Code: NCT06239194
Phase1, Phase2, Recruiting
A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors
for
Colorectal Cancer, Triple Negative Breast Cancer,
Location: New York NY, Tampa FL, Columbus OH, Atlanta GA,
Sponsor: OncXerna Theraputics, Inc.
Sex: All
Age: 18+
Code: NCT05453825
Phase2, Recruiting
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor